We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Federal Circuit Denies Genzyme’s Rehearing Request in Muscle Therapy Patent Suit
Federal Circuit Denies Genzyme’s Rehearing Request in Muscle Therapy Patent Suit
A federal appeals court rejected Genzyme’s rehearing request in a lawsuit that alleges the Patent Trial and Appeal Board violated protocol when it invalidated the company’s patent covering treatment methods for a rare muscle disease.